Based on the DR Horton Inc stock forecast from 11 analysts, the average analyst target price for DR Horton Inc is USD 195.38 over the next 12 months. DR Horton Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of DR Horton Inc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, DR Horton Inc’s stock price was USD 163.12. DR Horton Inc’s stock price has changed by +1.24% over the past week, -16.16% over the past month and +27.04% over the last year.
No recent analyst target price found for DR Horton Inc
No recent average analyst rating found for DR Horton Inc
Company Overview DR Horton Inc
D.R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 118 markets across 33 states under the names of D.R. Horton, America's Builder, Express Homes, Emerald Homes, and Freedom Homes. The company constructs and sells single-family detached homes; and attached homes, such as townhomes, duplexes, and triplexes. It also provides mortgage financing services; and title insurance policies, and examination and closing services, as well as engages in the residential lot development business. In addition, the company develops, constructs, owns, leases, and sells multi-family and single-family rental properties; and owns non-residential real estate, including ranch land and improvements. It primarily serves homebuyers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Arlington, Texas. Read Less
D.R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 118 markets across 33 sta...Read More
Frequently Asked Questions About DR Horton Inc (DHI) Stock
Based on ratings from 11 analysts DR Horton Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 11 buy, 1 sell and 4 hold ratings.
DHI stock's dividend yield is 0.95%.
Our analysis grades DHI stock's dividend yield at D+. This means that DHI stock's dividend yield is above 67% of the stocks in the Residential Construction sector in the NYE exchange.
Based on this DHI may be a average dividend stock for its sector.
Based on targets from 11 analysts, the average taret price for DHI is USD 195.38 over the next 12 months. The maximum analyst target price is USD 220 while the minimum anlayst target price is USD 154.
DHI stock's Price/Earning ratio is 11.91.
Our analysis grades DHI stock's Price / Earning ratio at F. This means that DHI stock's Price/Earning ratio is above 57.00000000000001% of the stocks in the Residential Construction sector in the NYE exchange.
Based on this DHI may be a overvalued for its sector.
The last closing price of DHI's stock was USD 163.12.
The most recent market capitalization for DHI is USD 55.32B.
Based on targets from 11 analysts, the average taret price for DHI is projected at USD 195.38 over the next 12 months.
This means that DHI's stock price may go up by +19.77% over the next 12 months.
We can't find any ETFs which contains DR Horton Inc's stock.
As per our most recent records DR Horton Inc has 0 Employees.
DR Horton Inc's registered address is 1341 Horton Circle, Arlington, TX, United States, 76011.
You can get more information about it from DR Horton Inc's website at https://www.drhorton.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About DR Horton Inc (DHI) Stock
Based on ratings from 11 analysts DR Horton Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 11 buy, 1 sell and 4 hold ratings.
DHI stock's dividend yield is 0.95%.
Our analysis grades DHI stock's dividend yield at D+. This means that DHI stock's dividend yield is above 67% of the stocks in the Residential Construction sector in the NYE exchange.
Based on this DHI may be a average dividend stock for its sector.
Based on targets from 11 analysts, the average taret price for DHI is USD 195.38 over the next 12 months. The maximum analyst target price is USD 220 while the minimum anlayst target price is USD 154.
DHI stock's Price/Earning ratio is 11.91.
Our analysis grades DHI stock's Price / Earning ratio at F. This means that DHI stock's Price/Earning ratio is above 57.00000000000001% of the stocks in the Residential Construction sector in the NYE exchange.
Based on this DHI may be a overvalued for its sector.
The last closing price of DHI's stock was USD 163.12.
The most recent market capitalization for DHI is USD 55.32B.
Based on targets from 11 analysts, the average taret price for DHI is projected at USD 195.38 over the next 12 months.
This means that DHI's stock price may go up by +19.77% over the next 12 months.
We can't find any ETFs which contains DR Horton Inc's stock.
As per our most recent records DR Horton Inc has 0 Employees.
DR Horton Inc's registered address is 1341 Horton Circle, Arlington, TX, United States, 76011.
You can get more information about it from DR Horton Inc's website at https://www.drhorton.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DHI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
